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Abstract
A ruthenium complex bearing an “anti-Bredt” N-heterocyclic carbene was synthesized, 
characterized and evaluated as a catalyst for olefin metathesis. Good conversions were observed at 
room temperature for the formation of di- and tri-substituted olefins by ring-closing metathesis. It 
also allowed for the ring-opening metathesis polymerization of cyclooctadiene, as well as for the 
cross-metathesis of cis-1,4-diacetoxy-2-butene with allyl-benzene, with enhanced Z/E kinetic 
selectivity over classical NHC-based catalysts.
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N-Heterocyclic carbene ligands have become key components of the [L2X2Ru═CHR] 
olefin metathesis catalysts.[1] The replacement of one phosphine in catalyst 1 by an 
imidazolidinylidene (catalyst 2) results in significant enhancements (Scheme 1), which have 
been attributed to the superior electronic donation of the carbene ligand and the ensuing 
increased affinity of the ruthenium center for π-acidic olefins.[2,3] Note that an extra gain in 
stability can be achieved by replacement of the remaining phosphine with a chelating ether 
(catalyst 3).[4]
For some time, the carbene ligand on ruthenium had been limited to imidazolylidenes, 
imidazolidinylidenes and closely related cyclic di(amino)carbenes.[5,6] These so-called 
NHCs are poor π-acceptors and cover a narrow range of σ-donation.[7] More recently, 
several examples of π-accepting stable cyclic carbenes have been developed, thus providing 
new opportunities for tuning the ruthenium center. Complexes of cyclic (alkyl)
(amino)carbenes 4 (CAACs)[8] and of di(amido)-carbenes 5 (DACs)[9] have demonstrated 
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interesting activities and selectivities for several ring-closing metathesis and cross-
metathesis reactions.[10–12] For instance, DAC-ruthenium complex 5 catalyzes the ring-
closing metathesis (RCM) of tetra-substituted olefins, a challenging transformation that is 
accomplished by only a limited range of metathesis catalysts.[11,13] However, note that this 
was found to be also the case for catalyst 6, which bears a non-electrophilic NHC with a 
similar steric environment to 5. The beneficial effect of π-accepting properties of the ligand 
is more obvious in the CAAC series. Indeed, complex 4a has the highest reported TON 
value (340,000) for ethenolysis reactions to date.[12] It vastly surpasses the more traditional 
catalysts 1–3 (TONs of only 2,000–5,000). Note that sterics also play a role, as 4b is more 
active than 4c or 4d by several orders of magnitude. More generally, both subtle changes in 
electronic and steric properties of the ligands can account for dramatic changes in activity, 
stability or selectivity. Therefore there is no single best ruthenium catalyst for all metathesis 
transformations, and new improvements in the field require a continuous effort to design 
new catalysts.[13]
We recently reported “anti-Bredt” N-heterocyclic carbenes featuring one nitrogen atom in a 
strained bridgehead position.[14] These ligands are significantly more π-accepting than 
NHCs, while retaining their strong σ-donation. They also feature a unique low steric 
hindrance on the side of the bridgehead nitrogen. Interestingly, they were found to be 
superior to CAAC and cyclic di(amino)carbenes as ligands for the gold-catalyzed 
intermolecular hydroamination of alkynes by hydrazine.[15] In addition, they allow for the 
challenging gold(I)-catalyzed hydroarylation of N,N-di(alkyl)anilines.[16] Herein we report 
the synthesis of the “anti-Bredt” NHC ruthenium complex 7 and its evaluation as a catalyst, 
using a set of standardized olefin metathesis reactions.[13]
Complex 7 was synthesized by deprotonation of the anti-Bredt imidazolium salt 8 in THF at 
−78°C, generating the free carbene, followed by the addition in situ of ruthenium complex 9 
(Scheme 2). The consumption of 9 and the formation of free triphenyl-phosphine were 
monitored by 31P NMR spectroscopy. After completion of the reaction and work-up, 
complex 7 was isolated as green crystals in 89% yield and fully characterized, including a 
single crystal X-ray diffraction study.[17]
In the solid state, the ruthenium center of 7 has a distorted square-pyramidal environment, 
the apical position being occupied by the benzylidene ligand (Figure 1). The Ru1–C1 (192.6 
pm) and Ru1–O1 (232.4 pm) bond lengths are comparable to those in CAAC-complexes 
4.[10] In contrast, the tetrahydropyrimidin-2-ylidene complex 6 features a significantly 
longer Ru1–C1 bond length (204.8 pm).[11] This is consistent with an increased double bond 
character of the metal-carbene bond of the anti-Bredt NHC complex, which is due to the 
superior π-accepting capabilities of the carbene.
The N-aryl substituent of the stable carbene is located above the benzylidene ligand. 
Interestingly, the same orientation was found in CAAC-complexes 4. This was interpreted as 
the result of negative steric interactions, which would prevent the alkyl groups of the 
quaternary carbon of CAAC to approach the benzylidene proton.[10] This explanation is 
clearly irrelevant in the case of the anti-Bredt NHC ligand, which features a non-bulky 
distorted amino group in place of the quaternary carbon of CAACs. The preferred 
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conformation of 7 in the solid state could be governed by unfavorable steric interactions 
between the chlorides and the N-2,6-di(isopropyl)phenyl groups. This is suggested by the 
examination of the hypothetical structure resulting from the simple 180° rotation of the 
ligand around the C–Ru bond of 7, which brings the isopropyl groups in very close 
proximity to the chlorine atoms (see the Supporting Information). The shortest carbon-
chloride distance is 278 pm, the Van der Walls radii of these atoms being 170 pm and 175 
pm, respectively. However, note that we found no evidence that the solid-state conformation 
is maintained in solution.
Complex 7 promotes the classical ring-closing metathesis (RCM) of diethyl dialkylmalonate 
10a. After 30 min at room temperature, 90% of the starting material was converted into the 
corresponding cyclopentene 11a with 1% catalyst loading. Complete conversion was 
reached within 2 h (Table 1, entries 1 and 2). In contrast, catalysts bearing bulky CAAC 4c 
and 4d, 6-membered ring NHC 5, and DAC 6 require higher temperature to reach decent 
conversions (entries 6–9). Complex 7 compares well with benchmark catalysts 2 and 3 and 
CAAC-complex 4b, which benefits from a smaller N-aryl substituent than in 4c and 4d 
(entries 3–5). This remains the case for the synthesis of the more challenging trisubstituted 
olefin 11b (entries 10–14). However, whereas 90% of the starting material 10b was 
transformed within 30 min in presence of 1% of 7, the conversion did not improve after one 
night, likely due to decomposition of the catalyst.
Complex 7 did not catalyze the formation of the tetra-substituted olefin 11c from malonate 
(entries 15 and 16). CAAC ligands (catalysts 4a–c), which are comparable to anti-Bredt 
NHCs in terms of electronic properties, suffer from the same limitation, whereas 2 and 3 
afford up to 64% conversion (entries 17–19). Robustness of the catalyst is known to play a 
key role in the very challenging RCM of 10c, which typically occurs at elevated 
temperatures.[13] This is well illustrated by 5 and 6, which are moderately active in RCM 
(entries 8 and 9), but have a good thermal stability and still allow for the formation of 11c at 
100°C (entries 20 and 21). Note that even after a night at 100°C complex 7 could still be 
detected by 1H NMR. This suggested that the catalyst could survive the experimental 
conditions and was just inert toward the substrate.
Catalyst 7 was also tested in cross-metathesis reactions. With 2.5% catalyst loading, the 
reaction between cis-1,4-diacetoxy-2-butene and allylbenzene reached 98% conversion in 3 
h. Relative to catalysts 2 and 3, 7 is slightly less active, but exhibits an enhanced Z/E ratio at 
higher conversion (Table 2, entries 1–3). Note that similar kinetic selectivity was reported 
with CAAC-based catalyst 4b (entry 4).
The catalyst was significantly less active in cross-metathesis of hex-5-en-1-yl acetate with 
methyl acrylate, a very challenging electron-poor olefin. Indeed only 23% conversion was 
obtained after 20 h under standard conditions, whereas the reaction reaches completion 
within 2–8 h with catalysts 2 and 3 (Table 3).
Finally, we confirmed that 7 could promote ring-opening metathesis polymerization 
(ROMP).[1g,18] For this reaction the stability of the catalyst has usually a marginal role, the 
catalytic activity having the major contribution to the overall catalytic performance.[13] 
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According to NMR monitoring, the polymerization of cyclooctadiene occurred in 1 hour in 
the presence of 0.1% of 7. This is in line with the results obtained in the previous test 
reactions. Indeed this fair activity is moderate when compared to benchmark catalysts 2 and 
3, which afford 99% polymerization within 6 min under similar conditions (Table 4).
In conclusion, the anti-Bredt NHC ruthenium complex 7 was synthesized, characterized and 
evaluated as a catalyst for olefin metathesis reactions. It was found to be highly active in 
RCM, with good and fast conversions being observed at room temperature for the formation 
of di- and tri-substituted olefins. However, it was inactive for the formation of tetra-
substituted olefins. It allowed for ROMP, as well as for the cross-metathesis of cis-1,4-
diacetoxy-2-butene with allylbenzene with a 70% E selectivity at 98% conversion. It is a 
poor catalyst for the more challenging cross-metathesis of hex-5-en-1-yl acetate with methyl 
acrylate.
The fact that these results are reminiscent of the activity of catalyst 4b is in line with the 
similarity of anti-Bredt NHCs and CAACs in terms of electronic properties. Previous 
screening of CAAC-based catalysts demonstrated the importance of tuning the steric 
environment of the ruthenium center, especially by varying the N-substituent of the carbene 
ligand. However, in the case of anti-Bredt NHCs, only the free carbene bearing a 2,3-
di(isopropyl)phenyl amino group is available. To date, all attempts to deprotonate precursors 
of these carbenes featuring smaller N-substituents have led to side-reactions under kinetic 
control, such as the formation of azomethine ylides. Therefore, the synthetic challenge of 
increasing the structural diversity of anti-Bredt NHC ruthenium complexes remains to be 
addressed.
Experimental Section
General Considerations
Experiments were performed under an inert atmosphere of dry argon, using standard 
Schlenk and dry-box techniques, dry and oxygen-free solvents. Toluene, THF and pentane 
were distilled over sodium under argon atmosphere prior use. Dichloromethane was dried 
via elution through a solvent column drying system. CD2Cl2 and C6D6 were distilled from 
CaH2. Allylbenzene, tridecane, and cis-1,4-diacetoxy-2-butene were distilled from 
anhydrous potassium carbonate prior to use. KHMDS, ethyl acrylate, hex-5-en-1-yl acetate, 
and anthracene were purchased from Aldrich, stored under Ar, and otherwise used as 
received. 1,5-Cyclooctadiene was distilled under Ar immediately prior to the polymerization 
reaction. 1H and 13C NMR spectra were recorded on Bruker Avance 300 spectrometer. 
Chemical shifts are given relative to SiMe4 and referenced to the residual solvent signal. 
Melting points were measured with an Electrothermal MEL-TEMP apparatus. All 
metathesis reactions were conducted according to the protocol described in ref.[13]
{3-(2,6-Diisopropylphenyl)-1,3-diaza[3.3.1]non-2-ylidene]dichloro(2-
isopropoxyphenylmethylene)-ruthenium (7)—Under an argon atmosphere, 
amidinium triflate 8[14] (140 mg, 0.32 mmol) was dissolved in THF (6 mL) and slowly 
added to a stirred solution of KHMDS (70 mg, 0.35 mmol) in THF (3 mL) at −78°C. After 5 
min, Cl2Ru[=CHC6H4-o-(i-Pr)]PPh3 9 (158 mg, 0.27 mmol)[19] in THF (10 mL) was added. 
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The resulting mixture was warmed up to room temperature and stirred overnight. The 
volatiles were removed under vacuum. The residues were washed two times with pentane 
and the product was extracted three times with toluene. The combined toluene fractions were 
concentrated under vacuum and pentane was slowly layered, affording compound 7 as green 
crystals; yield: 145 mg (89%); mp 130–133°C. MS: m/z=605.1638 [M+H]+, calculated for 
C29H41N2ORuCl2: 605.1636; 1H NMR (CDCl3, 300 MHz): δ=16.2 (s, 1H), 7.6–7.2 (m, 
4H), 6.9–6.8 (m, 3H), 5.30 (m, 1H), 5.09 (pseudo sept, J=6 Hz, 1H), 3.8–3.6 (m, 3H), 3.51 
(d, J=12 Hz, 1H), 3.36 (d, J=12 Hz, 1H), 3.18 (sept, J=6 Hz, 2H), 2.62 (m, 1H), 2.2–1.5 (m, 
4H), 1.79 (d, J=6 Hz, 3H), 1.77 (d, J=6 Hz, 3H), 1.30 (d, J= 6 Hz, 3H), 1.24 (d, J=6 Hz, 3H), 
0.94 (d, J=6 Hz, 3H), 0.88 (d, J=6 Hz, 3H); 13C NMR (CDCl3, 75 MHz): δ = 295.8 
(Ru=CH), 253.3 (RuCN2), 152.5 (Caro), 146.7 (Caro), 146.5 (Caro), 144.1 (Caro), 142.0 
(Caro), 130.2 (CHaro), 129.6 (CHaro), 125.5 (CHaro), 125.3 (CHaro), 123.1 (CHaro), 121.9 
(CHaro), 113.0 (CHaro), 74.6 (OCH), 62.2 (CH2), 52.3 (CH2), 50.5 (CH2), 30.9 (CH), 29.7 
(CH2), 29.2 (CH2), 28.2 (CH3), 27.7 (CH3), 25.9 (CH3), 25.7 (CH3), 24.1 (CH3), 23.9 (CH), 
22.2 (CH3).
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Figure 1. 
Solid state structure of 7 with ellipsoids drawn at 50% probability level. Hydrogen atoms 
have been omitted for clarity. Selected bond lengths (Å) and angles (°): Ru1– C1 1.926(6), 
Ru1–O1 2.324(4), Ru1–C26 1.813(7), Ru1–Cl1 2.3374(16), Ru1–Cl2 2.3278(17), N1–C1 
1.452(8), N2–C1 1.330(8), N1–C1–N2 114.6(5), C1–Ru1–C26 105.4(3), Cl1– Ru1–Cl2 
154.27(7).
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Scheme 1. 
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Scheme 2. 
Synthesis of complex 7.
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Table 2
Cross-metathesis of cis-1,4-diacetoxy-2-butene with allylbenzene.
Entry Catalyst Time [h] Conversion (% E)
1 7 1 52% (70)
2 7 3 98% (70)
3[a] 2 0.5 79% (91)
4[a] 3 0.5 72% (91)
5[b] 4b 1 60% (66)
[a]
Ref.[13]
[b]
Ref.[10b]
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Table 3
Cross-metathesis of methyl acrylate with hex-5-en-1-yl acetate.
Entry Catalyst Time [h] Conversion
1 7 20 23%
2[a] 2 2 98%
3[a] 3 8 96%
[a]
Ref.[13]
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Table 4
Ring-opening metathesis polymerization of cyclooc-ta-1,5-diene.
Entry Catalyst Time [min] Conversion
1 7 60 98%
2[a] 1 60 32%
3[a] 2 6 99%
4[a] 3 6 99%
[a]
Ref.[13]
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